H2AX and acute myeloid leukemia: The loss of H2AX increased chromosomal instability seen in acute myeloid leukemia, acute lymphoid leukemia, and Head and neck squamous cell may contribute to tumor development, progression, and resistance to therapy in this cancer subtype (Thirman et al., 1993; Parikh et al., 2007).